| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 3 | 0 | 0 | 3 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
| Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
| Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
| Chain A, Endochitinase | 0 | 1 | 0 | 1 |
| Chain A, Endochitinase | 0 | 1 | 0 | 1 |
| Chain A, Endochitinase | 0 | 1 | 0 | 1 |
| Chain A, Class Iii Chitinase Chia1 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Chain B, Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| thioredoxin reductase | 2 | 0 | 0 | 2 |
| GALC protein | 2 | 0 | 0 | 2 |
| GLI family zinc finger 3 | 4 | 0 | 0 | 4 |
| nuclear receptor subfamily 1, group I, member 3 | 4 | 0 | 0 | 4 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 6 | 0 | 0 | 6 |
| glucocorticoid receptor [Homo sapiens] | 5 | 0 | 0 | 5 |
| retinoic acid nuclear receptor alpha variant 1 | 4 | 0 | 0 | 4 |
| retinoid X nuclear receptor alpha | 4 | 0 | 0 | 4 |
| estrogen-related nuclear receptor alpha | 5 | 0 | 0 | 5 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| arylsulfatase A | 2 | 0 | 0 | 2 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| euchromatic histone-lysine N-methyltransferase 2 | 3 | 0 | 0 | 3 |
| Bloom syndrome protein isoform 1 | 3 | 0 | 0 | 3 |
| thyroid hormone receptor beta isoform a | 4 | 0 | 0 | 4 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 6 | 0 | 0 | 6 |
| geminin | 4 | 0 | 0 | 4 |
| peripheral myelin protein 22 | 4 | 0 | 0 | 4 |
| survival motor neuron protein isoform d | 4 | 0 | 0 | 4 |
| muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit pi | 5 | 3 | 0 | 8 |
| ATP-binding cassette sub-family C member 3 | 0 | 4 | 0 | 4 |
| Multidrug resistance-associated protein 4 | 0 | 4 | 0 | 4 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 12 | 0 | 2 | 1 | 5 |
| Prolyl endopeptidase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase-related protein 11 | 0 | 1 | 0 | 2 |
| Bile salt export pump | 0 | 4 | 0 | 4 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Renin | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 1 | 0 | 3 | 1 | 8 |
| Carbonic anhydrase 2 | 0 | 3 | 1 | 7 |
| Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 3 | 0 | 2 | 1 | 5 |
| Cathepsin B | 0 | 1 | 0 | 1 |
| Cytochrome P450 3A4 | 0 | 2 | 0 | 2 |
| Steryl-sulfatase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C9 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
| Androgen receptor | 0 | 5 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 5 | 3 | 0 | 8 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 5 | 3 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 5 | 3 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 5 | 3 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 5 | 3 | 0 | 8 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 2 | 1 | 4 |
| Carbonic anhydrase 6 | 0 | 2 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 5 | 3 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 5 | 3 | 0 | 8 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 2 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 5 | 3 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 5 | 3 | 0 | 8 |
| Endochitinase | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 5 | 3 | 0 | 8 |
| Adenosine receptor A2a | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
| Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 1 | 5 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 7 | 0 | 2 | 1 | 4 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 0 | 1 | 0 | 1 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 5 | 3 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 5 | 3 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 5 | 3 | 0 | 8 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
| Squalene synthase | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 9 | 0 | 2 | 1 | 5 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Renin | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Endochitinase A1 | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 2 | 1 | 4 |
| GABA theta subunit | 5 | 3 | 0 | 8 |
| Canalicular multispecific organic anion transporter 1 | 0 | 3 | 0 | 3 |
| Carbonic anhydrase 4 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 15 | 0 | 1 | 0 | 2 |
| Acidic mammalian chitinase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 2 | 0 | 3 |
| Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 5 | 3 | 0 | 8 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 2 | 1 | 5 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2, isoform A | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 1 | 5 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 2 | 0 | 0 | 2 |
| Chain A, Cruzipain | 1 | 0 | 0 | 1 |
| Luciferase | 4 | 0 | 0 | 4 |
| estrogen nuclear receptor alpha | 5 | 0 | 0 | 5 |
| G | 4 | 0 | 0 | 4 |
| peroxisome proliferator activated receptor gamma | 4 | 0 | 0 | 4 |
| lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
| mitogen-activated protein kinase 1 | 4 | 0 | 0 | 4 |
| cytochrome P450 3A4 isoform 1 | 5 | 0 | 0 | 5 |
| lamin isoform A-delta10 | 5 | 0 | 0 | 5 |
| Interferon beta | 5 | 0 | 0 | 5 |
| HLA class I histocompatibility antigen, B alpha chain | 4 | 0 | 0 | 4 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 1 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
| Thromboxane A2 receptor | 0 | 0 | 0 | 1 |
| Endothelin-1 receptor | 0 | 1 | 0 | 1 |
| Type-1B angiotensin II receptor | 0 | 1 | 0 | 1 |
| Type-1 angiotensin II receptor | 0 | 2 | 0 | 3 |
| Type-2 angiotensin II receptor | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 4 | 0 | 4 |
| Sodium/bile acid cotransporter | 0 | 2 | 0 | 2 |
| Inositol hexakisphosphate kinase 1 | 4 | 0 | 0 | 4 |
| Multidrug and toxin extrusion protein 1 | 0 | 4 | 0 | 4 |
| Leukotriene B4 receptor 2 | 0 | 0 | 1 | 1 |
| cytochrome P450 2C9, partial | 4 | 0 | 0 | 4 |
| Chain A, Estrogen-related receptor gamma | 0 | 0 | 1 | 1 |
| Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
| Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
| Chain A, Estrogen-related receptor gamma | 0 | 0 | 1 | 1 |
| Chain A, Estrogen-related receptor gamma | 0 | 0 | 1 | 1 |
| Chain A, Estrogen-related receptor gamma | 0 | 0 | 1 | 1 |
| acetylcholinesterase | 3 | 0 | 0 | 3 |
| glp-1 receptor, partial | 4 | 0 | 0 | 4 |
| RAR-related orphan receptor gamma | 3 | 0 | 0 | 3 |
| GLS protein | 4 | 0 | 0 | 4 |
| TDP1 protein | 4 | 0 | 0 | 4 |
| AR protein | 3 | 0 | 0 | 3 |
| caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
| thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
| estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
| progesterone receptor | 3 | 0 | 0 | 3 |
| farnesoid X nuclear receptor | 3 | 0 | 0 | 3 |
| pregnane X nuclear receptor | 3 | 0 | 0 | 3 |
| cytochrome P450 2D6 | 4 | 0 | 0 | 4 |
| peroxisome proliferator-activated receptor delta | 3 | 0 | 0 | 3 |
| caspase-3 | 1 | 0 | 0 | 1 |
| aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 4 | 0 | 0 | 4 |
| thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 3 | 0 | 0 | 3 |
| Histone H2A.x | 3 | 0 | 0 | 3 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform 2 | 4 | 0 | 0 | 4 |
| importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
| snurportin-1 | 2 | 0 | 0 | 2 |
| GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
| Voltage-dependent calcium channel gamma-2 subunit | 3 | 0 | 0 | 3 |
| GTPase KRas | 0 | 0 | 1 | 1 |
| Estrogen receptor | 0 | 6 | 3 | 9 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 2 | 0 | 2 |
| Cellular tumor antigen p53 | 3 | 0 | 0 | 3 |
| Aldo-keto reductase family 1 member B1 | 0 | 6 | 0 | 6 |
| Androgen receptor | 0 | 2 | 0 | 3 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 4 | 0 | 4 |
| Glutamate receptor 2 | 3 | 0 | 0 | 3 |
| Sodium-dependent noradrenaline transporter | 0 | 6 | 0 | 6 |
| Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 6 | 0 | 4 | 0 | 5 |
| Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
| Estrogen-related receptor gamma | 0 | 1 | 1 | 2 |
| Sodium-dependent dopamine transporter | 0 | 6 | 0 | 6 |
| GTP-binding protein Rheb | 0 | 0 | 1 | 1 |
| Estrogen receptor beta | 0 | 5 | 3 | 8 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 2 | 0 | 0 | 2 |
| Chain A, Ferritin light chain | 4 | 0 | 0 | 4 |
| interleukin 8 | 1 | 0 | 0 | 1 |
| 15-lipoxygenase, partial | 3 | 0 | 0 | 3 |
| hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
| ATAD5 protein, partial | 3 | 0 | 0 | 3 |
| USP1 protein, partial | 2 | 0 | 0 | 2 |
| Microtubule-associated protein tau | 2 | 0 | 0 | 2 |
| Smad3 | 2 | 0 | 0 | 2 |
| aldehyde dehydrogenase 1 family, member A1 | 2 | 0 | 0 | 2 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
| regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
| 67.9K protein | 3 | 0 | 0 | 3 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 2 | 0 | 0 | 2 |
| IDH1 | 2 | 0 | 0 | 2 |
| activating transcription factor 6 | 2 | 0 | 0 | 2 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 1 | 0 | 0 | 1 |
| cellular tumor antigen p53 isoform a | 3 | 0 | 0 | 3 |
| vitamin D3 receptor isoform VDRA | 2 | 0 | 0 | 2 |
| heat shock protein beta-1 | 1 | 0 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 2 | 0 | 0 | 2 |
| serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 2 | 0 | 0 | 2 |
| nuclear receptor ROR-gamma isoform 1 | 2 | 0 | 0 | 2 |
| high affinity choline transporter 1 isoform a | 0 | 1 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
| lethal factor (plasmid) | 2 | 0 | 0 | 2 |
| neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
| 5-hydroxytryptamine receptor 4 | 0 | 6 | 0 | 6 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 1 | 0 | 1 |
| Glucocorticoid receptor | 0 | 2 | 0 | 3 |
| Integrin beta-3 | 3 | 1 | 0 | 4 |
| Tyrosine-protein kinase Fyn | 0 | 3 | 0 | 3 |
| Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
| Integrin alpha-IIb | 3 | 1 | 0 | 4 |
| Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
| Adenosine receptor A3 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M1 | 0 | 4 | 0 | 4 |
| D(2) dopamine receptor | 0 | 3 | 0 | 3 |
| Alpha-1B adrenergic receptor | 0 | 3 | 0 | 3 |
| Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Thromboxane-A synthase | 0 | 2 | 0 | 2 |
| Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 2C | 0 | 6 | 0 | 6 |
| Adenosine receptor A2a | 0 | 4 | 0 | 4 |
| Adenosine receptor A1 | 0 | 4 | 0 | 4 |
| Mu-type opioid receptor | 0 | 2 | 0 | 2 |
| D(3) dopamine receptor | 0 | 2 | 0 | 2 |
| Vasopressin V1a receptor | 0 | 2 | 0 | 2 |
| Alpha-synuclein | 1 | 0 | 0 | 1 |
| Delta-type opioid receptor | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
| Alpha-1A adrenergic receptor | 0 | 3 | 0 | 3 |
| Histamine H2 receptor | 3 | 0 | 0 | 3 |
| Spike glycoprotein | 3 | 0 | 0 | 3 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
| Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
| Aldehyde oxidase | 0 | 2 | 0 | 2 |
| TAR DNA-binding protein 43 | 1 | 1 | 0 | 2 |
| UDP-glucose 4-epimerase | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 14 | 0 | 2 | 0 | 2 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 3 | 0 | 4 |
| Cysteinyl leukotriene receptor 1 | 0 | 2 | 0 | 2 |
| Chain A, Estrogen receptor 1 (alpha) | 0 | 1 | 0 | 1 |
| Chain A, Transthyretin | 0 | 0 | 1 | 1 |
| Chain A, Transthyretin | 0 | 0 | 1 | 1 |
| acid sphingomyelinase | 1 | 0 | 0 | 1 |
| BRCA1 | 1 | 0 | 0 | 1 |
| SMAD family member 2 | 1 | 0 | 0 | 1 |
| PPM1D protein | 2 | 0 | 0 | 2 |
| SMAD family member 3 | 1 | 0 | 0 | 1 |
| Thrombopoietin | 2 | 0 | 0 | 2 |
| EWS/FLI fusion protein | 4 | 0 | 0 | 4 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| glucocerebrosidase | 1 | 0 | 0 | 1 |
| Parkin | 2 | 0 | 0 | 2 |
| P53 | 1 | 0 | 0 | 1 |
| Alpha-mannosidase | 0 | 1 | 0 | 1 |
| pyruvate kinase | 2 | 0 | 0 | 2 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
| hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
| NPC intracellular cholesterol transporter 1 precursor | 2 | 0 | 0 | 2 |
| peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
| cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
| cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| glucokinase regulatory protein | 1 | 0 | 0 | 1 |
| glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
| DNA polymerase beta | 1 | 0 | 0 | 1 |
| flap endonuclease 1 | 2 | 0 | 0 | 2 |
| ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
| tyrosine-protein kinase Yes | 2 | 0 | 0 | 2 |
| urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
| plasminogen precursor | 1 | 0 | 0 | 1 |
| urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
| M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
| pyruvate kinase PKM isoform b | 2 | 0 | 0 | 2 |
| Maltase-glucoamylase, intestinal | 0 | 2 | 0 | 2 |
| Steroid hormone receptor ERR2 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase ABL1 | 0 | 1 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
| Pancreatic triacylglycerol lipase | 0 | 1 | 0 | 1 |
| Triosephosphate isomerase | 0 | 1 | 0 | 1 |
| Transthyretin | 0 | 1 | 0 | 1 |
| Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 1 | 2 |
| Ornithine decarboxylase | 2 | 0 | 0 | 2 |
| Sialidase | 0 | 1 | 0 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 1 | 0 | 1 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| Steroid hormone receptor ERR1 | 0 | 1 | 0 | 1 |
| Aromatase | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 4 | 0 | 1 | 0 | 1 |
| Ornithine decarboxylase | 0 | 1 | 0 | 1 |
| Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
| Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 1 | 1 |
| 17-beta-hydroxysteroid dehydrogenase type 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 4 | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B1 | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Protein kinase C alpha type | 0 | 1 | 0 | 1 |
| cAMP-dependent protein kinase catalytic subunit alpha | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| G1/S-specific cyclin-D1 | 0 | 1 | 0 | 1 |
| Cruzipain | 0 | 1 | 0 | 1 |
| DNA (cytosine-5)-methyltransferase 1 | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-5 | 0 | 1 | 0 | 1 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| RAC-alpha serine/threonine-protein kinase | 0 | 1 | 0 | 1 |
| Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 1 | 1 |
| Testosterone 17-beta-dehydrogenase 3 | 0 | 1 | 0 | 1 |
| 17-beta-hydroxysteroid dehydrogenase type 2 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Alpha-glucosidase MAL32 | 0 | 1 | 0 | 1 |
| Signal transducer and activator of transcription 3 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase CSK | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase ABL2 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase SYK | 0 | 1 | 0 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 4 | 0 | 1 | 0 | 1 |
| Quinone oxidoreductase | 0 | 0 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
| Cytoplasmic tyrosine-protein kinase BMX | 0 | 1 | 0 | 1 |
| Death-associated protein kinase 1 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 10 | 0 | 1 | 0 | 1 |
| Oxysterols receptor LXR-beta | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
| MO15-related protein kinase Pfmrk | 0 | 1 | 0 | 1 |
| Oxysterols receptor LXR-alpha | 0 | 1 | 0 | 1 |
| Tissue alpha-L-fucosidase | 0 | 1 | 0 | 1 |
| Substance-K receptor | 0 | 1 | 0 | 1 |
| Integrase | 0 | 2 | 0 | 2 |
| Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) | 0 | 1 | 0 | 1 |
| ATPase family AAA domain-containing protein 5 | 1 | 0 | 0 | 1 |
| Ataxin-2 | 2 | 0 | 0 | 2 |
| Prenyltransferase homolog | 0 | 0 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 4 | 0 | 4 |
| Dipeptidyl peptidase 3 | 0 | 1 | 0 | 1 |
| DNA (cytosine-5)-methyltransferase 3-like | 0 | 1 | 0 | 1 |
| Sialidase-2 | 0 | 1 | 0 | 1 |
| DNA (cytosine-5)-methyltransferase 3A | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 2 |
| histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
| Solute carrier family 22 member 2 | 0 | 3 | 0 | 3 |
| Solute carrier family 22 member 1 | 0 | 3 | 0 | 3 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 0 | 0 | 1 |
| Chain A, Probable serine/threonine-protein kinase pknB | 0 | 1 | 0 | 1 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| WRN | 1 | 0 | 0 | 1 |
| Fumarate hydratase | 1 | 0 | 0 | 1 |
| NFKB1 protein, partial | 1 | 0 | 0 | 1 |
| apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
| DNA polymerase III, partial | 1 | 0 | 0 | 1 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| nonstructural protein 1 | 0 | 1 | 0 | 1 |
| LANA | 0 | 0 | 0 | 1 |
| polyprotein | 1 | 0 | 0 | 1 |
| phospholipase A2, group III | 0 | 1 | 0 | 1 |
| cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
| interferon gamma precursor | 0 | 0 | 0 | 1 |
| atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
| histone-lysine N-methyltransferase NSD2 isoform 1 | 0 | 0 | 0 | 1 |
| chromobox protein homolog 1 | 1 | 0 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
| huntingtin isoform 2 | 1 | 0 | 0 | 1 |
| atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
| protein AF-9 isoform a | 0 | 0 | 0 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
| DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
| DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
| dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 0 | 0 | 1 |
| rac GTPase-activating protein 1 isoform a | 0 | 1 | 0 | 1 |
| DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
| Vpr | 1 | 0 | 0 | 1 |
| muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
| DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 2 | 0 | 2 |
| Glycoprotein hormones alpha chain | 1 | 0 | 0 | 1 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
| Amyloid-beta precursor protein | 1 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
| Proto-oncogene tyrosine-protein kinase ROS | 0 | 1 | 0 | 1 |
| DNA topoisomerase 2-alpha | 0 | 1 | 0 | 2 |
| Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
| DNA topoisomerase 2 | 0 | 0 | 0 | 1 |
| Casein kinase II subunit alpha' | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
| Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
| Casein kinase II subunit beta | 0 | 1 | 0 | 1 |
| Casein kinase II subunit alpha | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| DNA topoisomerase 2-beta | 0 | 0 | 0 | 1 |
| Tyrosine-protein kinase BTK | 0 | 1 | 0 | 1 |
| NEDD8-activating enzyme E1 regulatory subunit | 0 | 0 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
| Multidrug and toxin extrusion protein 2 | 0 | 2 | 0 | 2 |
| Casein kinase II subunit alpha 3 | 0 | 1 | 0 | 1 |
| NEDD8-activating enzyme E1 catalytic subunit | 0 | 0 | 1 | 1 |
| Single-stranded DNA cytosine deaminase | 1 | 0 | 0 | 1 |
| P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 1 | 0 | 0 | 1 |
| ATP-dependent phosphofructokinase | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 3E | 0 | 1 | 1 | 3 |
| 5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 3B | 0 | 1 | 1 | 3 |
| Muscarinic acetylcholine receptor M1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 0 | 2 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| D | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Interleukin-6 receptor subunit alpha | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
| Beta-3 adrenergic receptor | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
| Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1F | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
| Histamine H1 receptor | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 5B | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 3A | 0 | 2 | 1 | 4 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Thyrotropin-releasing hormone receptor | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Glycine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3D | 0 | 1 | 1 | 3 |
| 5-hydroxytryptamine receptor 3C | 0 | 1 | 1 | 3 |
| 5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3B | 0 | 2 | 1 | 3 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Leukotriene B4 receptor 1 | 0 | 1 | 0 | 1 |
| Nischarin | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |